Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DermTech, Inc.DMTK · Entity 89998 | Director | January 30, 2020 | February 03, 2020 |
| Mobiquity Technologies, Inc.MOBQ · Entity 7618 | Director · 10% owner | December 31, 2025 | January 02, 2026 |
| UPEXI, INC.UPXI · Entity 6954 | Director | July 03, 2026 | July 20, 2026 |
| Z Squared Inc.COEP · Entity 6495 | Director | February 11, 2026 | February 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DermTech, Inc.
Report date January 30, 2020 · Filed February 03, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 179,154 |
Reported balance
After 2020-01-30 transaction · row 1
1 source rowRow 1 · 2020-01-30 · Grant · Acquired 6,000 · Balance 179,154 F1: The securities awarded are in the form of restricted stock units issued pursuant to the issuer's Amended and Restated 2010 Stock Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, all of the restricted stock units shall vest in a single installment on the date of the 2020 annual meeting of the stockholders of the issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: The securities awarded are in the form of restricted stock units issued pursuant to the issuer's Amended and Restated 2010 Stock Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, all of the restricted stock units shall vest in a single installment on the date of the 2020 annual meeting of the stockholders of the issuer.
Mobiquity Technologies, Inc.
Report date December 31, 2025 · Filed January 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $1.10 · Expires 2030-12-31 | Direct | 761,544 |
Reported balance
After 2025-12-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-12-31 · Grant · Acquired 250,000 · Balance 761,544 F1: Not applicable. F2: Includes (i) 59,211 shares underlying warrants exercisable at $60 per share, (ii) 2,333 shares underlying options exercisable at $68.48 per share, (iii) 100,000 shares underlying options exercisable at $.20 per share, (iv)100,000 shares underlying a convertible note at $1.00 per share, (v) options to purchase 250,000 shares exercisable at $2.45 per share, and (vi) options to purchase 250,000 exercisable at $1.10 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Not applicable.
F2: Includes (i) 59,211 shares underlying warrants exercisable at $60 per share, (ii) 2,333 shares underlying options exercisable at $68.48 per share, (iii) 100,000 shares underlying options exercisable at $.20 per share, (iv)100,000 shares underlying a convertible note at $1.00 per share, (v) options to purchase 250,000 shares exercisable at $2.45 per share, and (vi) options to purchase 250,000 exercisable at $1.10 per share.
UPEXI, INC.
Report date July 03, 2026 · Filed July 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 318,750 |
Reported balance
After 2026-07-03 transaction · row 1
1 source rowRow 1 · 2026-07-03 · Grant · Acquired 100,000 · Balance 318,750 F1: Represents restricted stock granted pursuant to the Issuer's 2019 Incentive Stock Plan, as amended, that vests in four equal quarterly installments, with full vesting on July 1, 2027, subject to continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock granted pursuant to the Issuer's 2019 Incentive Stock Plan, as amended, that vests in four equal quarterly installments, with full vesting on July 1, 2027, subject to continued service.
Z Squared Inc.
Report date February 11, 2026 · Filed February 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 13,161 |
Reported balance
After 2026-02-11 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-02-11 · Exercise / conversion · Acquired 5,700 · Balance 13,161 F1: Represents the exercise price of shares purchased upon exercise of stock options. F3: Includes 4,211 shares of common stock that are held as JTWROS with Catherine Salkind. |
| Common StockSEC Table I · non-derivative | Direct | 13,161 |
Reported balance
After 2026-02-11 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-02-11 · Grant · Acquired 3,250 · Balance 13,161 F2: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock. F3: Includes 4,211 shares of common stock that are held as JTWROS with Catherine Salkind. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the exercise price of shares purchased upon exercise of stock options.
F2: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock.
F3: Includes 4,211 shares of common stock that are held as JTWROS with Catherine Salkind.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2021 Filed Oct 4, 2021 23:30 UTC | Mobiquity Technologies, Inc. MOBQ · Entity 7618 | Exercise / conversionCommon Stock | 375,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-21-004684 · ownership.xml · nonDerivative · entry 1 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,116,021 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Includes securities or derivative securities heldboth jointly with his spouse and in trust. F1 · price: Not applicable - reporting person converted oneshare of Series C preferred stock into 250 common shares and 250 warrants,exercisable at $48 per share. Read SEC document |
| July 21, 2021 Filed Aug 30, 2021 23:18 UTC | UPEXI, INC. GRVI · Entity 6954 | GrantOption Grant · Derivative | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001279925-21-000006 · primary_doc.xml · derivative · entry 1 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · derivative.exercise_price: 50,000 options are vested and shall be exercisable for a price of $4.18 per option share for 2 years from July 21, 2021 (the "Grant Date"); such options shall vest on a monthly basis over a one year period and be exercisable for a price of $4.18 per option share for two years from the Grant Date. F1 · date: 50,000 options are vested and shall be exercisable for a price of $4.18 per option share for 2 years from July 21, 2021 (the "Grant Date"); such options shall vest on a monthly basis over a one year period and be exercisable for a price of $4.18 per option share for two years from the Grant Date. F1 · price: 50,000 options are vested and shall be exercisable for a price of $4.18 per option share for 2 years from July 21, 2021 (the "Grant Date"); such options shall vest on a monthly basis over a one year period and be exercisable for a price of $4.18 per option share for two years from the Grant Date. F1 · derivative.exercise_date: 50,000 options are vested and shall be exercisable for a price of $4.18 per option share for 2 years from July 21, 2021 (the "Grant Date"); such options shall vest on a monthly basis over a one year period and be exercisable for a price of $4.18 per option share for two years from the Grant Date. F1 · derivative.expiration_date: 50,000 options are vested and shall be exercisable for a price of $4.18 per option share for 2 years from July 21, 2021 (the "Grant Date"); such options shall vest on a monthly basis over a one year period and be exercisable for a price of $4.18 per option share for two years from the Grant Date. Read SEC document |
| April 01, 2021 Filed Apr 1, 2021 21:21 UTC | Mobiquity Technologies, Inc. MOBQ · Entity 7618 | GrantNotes · Derivative | 150,000 | Not disclosed Strike: $4.00 | Not disclosed |
DisclosureSEC source: 0001683168-21-001191 · ownership.xml · derivative · entry 1 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,684,375 Underlying: Common Stock · 56,250 shares Expires 2029-09-30 F1 · security: Includes securities held directly and in family Trusts. F2 · price: Not applicable. Read SEC document |
| September 08, 2020 Filed Sep 9, 2020 18:22 UTC | Mobiquity Technologies, Inc. MOBQ · Entity 7618 | GrantCommon Stock | 15,000,000 | $0.01 | $150,000.00 |
DisclosureSEC source: 0001683168-20-003070 · ownership.xml · nonDerivative · entry 1 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,318,355 F1 · security: Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares. F2 · security: Includes securities held directly and in family Trusts. Read SEC document |
| July 21, 2020 Filed Aug 4, 2020 18:39 UTC | Mobiquity Technologies, Inc. MOBQ · Entity 7618 | GrantCommon Stock | 15,000,000 | $0.01 | $150,000.00 |
DisclosureSEC source: 0001683168-20-002489 · ownership.xml · nonDerivative · entry 1 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,318,355 F1 · security: Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares. F2 · security: Includes securities held directly and in family Trusts. Read SEC document |
| January 30, 2020 Filed Feb 3, 2020 21:20 UTC | DermTech, Inc. DMTK · Entity 89998 | GrantCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-006005 · doc4.xml · nonDerivative · entry 1 Salkind Gene · CIK 0001592481 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,154 F1 · shares: The securities awarded are in the form of restricted stock units issued pursuant to the issuer's Amended and Restated 2010 Stock Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, all of the restricted stock units shall vest in a single installment on the date of the 2020 annual meeting of the stockholders of the issuer. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:17 UTC | DermTech, Inc. DMTK · Entity 89998 | Exercise / conversionRestricted Stock Units · Derivative | 7,593 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-000909 · doc4.xml · derivative · entry 2 Salkind Gene · CIK 0001592481 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,593 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The shares of Issuer common stock underlying these restricted stock units have fully vested and were released to the reporting person on December 31, 2019. F2 · derivative.expiration_date: The shares of Issuer common stock underlying these restricted stock units have fully vested and were released to the reporting person on December 31, 2019. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:17 UTC | DermTech, Inc. DMTK · Entity 89998 | Exercise / conversionCommon Stock | 7,593 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-000909 · doc4.xml · nonDerivative · entry 1 Salkind Gene · CIK 0001592481 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| September 13, 2019 Filed Sep 19, 2019 17:49 UTC | Mobiquity Technologies, Inc. MOBQ · Entity 7618 | GrantNotes · Derivative | 2,300,000 | Not disclosed Strike: $0.08 | Not disclosed |
DisclosureSEC source: 0001683168-19-002976 · ownership.xml · derivative · entry 4 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,502,500 Underlying: Common Stock · 28,750,000 shares Expires 2029-09-13 F2 · price: Not applicable. F4 · balance_after: Excludes 14,375,000 warrants issuable upon Note Conversion. Read SEC document |
| September 13, 2019 Filed Sep 19, 2019 17:49 UTC | Mobiquity Technologies, Inc. MOBQ · Entity 7618 | PurchaseCommon Stock | 12,500,000 | $0.04 | $500,000.00 |
DisclosureSEC source: 0001683168-19-002976 · ownership.xml · nonDerivative · entry 3 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,318,355 F1 · security: Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares. F3 · security: Includes securities held directly and in family Trusts. Read SEC document |
| September 13, 2019 Filed Sep 19, 2019 17:49 UTC | Mobiquity Technologies, Inc. MOBQ · Entity 7618 | PurchaseCommon Stock | 127,500,000 | $0.02 | $2,358,750.00 |
DisclosureSEC source: 0001683168-19-002976 · ownership.xml · nonDerivative · entry 2 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,818,355 F1 · security: Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares. F3 · security: Includes securities held directly and in family Trusts. Read SEC document |
| September 13, 2019 Filed Sep 19, 2019 17:49 UTC | Mobiquity Technologies, Inc. MOBQ · Entity 7618 | PurchaseCommon Stock | 35,000,000 | $0.01 | $336,000.00 |
DisclosureSEC source: 0001683168-19-002976 · ownership.xml · nonDerivative · entry 1 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,318,355 F1 · security: Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares. F3 · security: Includes securities held directly and in family Trusts. Read SEC document |
| September 13, 2019 Filed Jan 21, 2020 18:18 UTC Amendment | Mobiquity Technologies, Inc. MOBQ · Entity 7618 | GrantNotes · Derivative | 2,300,000 | Not disclosed Strike: $0.08 | Not disclosed |
DisclosureSEC source: 0001683168-20-000197 · ownership.xml · derivative · entry 4 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,502,500 Underlying: Common Stock · 28,750,000 shares Expires 2029-09-30 F2 · price: Not applicable. F4 · balance_after: Excludes 14,375,000 warrants issuable upon Note Conversion. Read SEC document |
| September 13, 2019 Filed Jan 21, 2020 18:18 UTC Amendment | Mobiquity Technologies, Inc. MOBQ · Entity 7618 | PurchaseCommon Stock | 12,500,000 | $0.04 | $500,000.00 |
DisclosureSEC source: 0001683168-20-000197 · ownership.xml · nonDerivative · entry 3 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,318,355 F1 · security: Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares. F3 · security: Includes securities held directly and in family Trusts. Read SEC document |
| September 13, 2019 Filed Jan 21, 2020 18:18 UTC Amendment | Mobiquity Technologies, Inc. MOBQ · Entity 7618 | PurchaseCommon Stock | 127,500,000 | $0.02 | $2,358,750.00 |
DisclosureSEC source: 0001683168-20-000197 · ownership.xml · nonDerivative · entry 2 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,818,355 F1 · security: Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares. F3 · security: Includes securities held directly and in family Trusts. Read SEC document |
| September 13, 2019 Filed Jan 21, 2020 18:18 UTC Amendment | Mobiquity Technologies, Inc. MOBQ · Entity 7618 | PurchaseCommon Stock | 35,000,000 | $0.01 | $336,000.00 |
DisclosureSEC source: 0001683168-20-000197 · ownership.xml · nonDerivative · entry 1 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,318,355 F1 · security: Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares. F3 · security: Includes securities held directly and in family Trusts. Read SEC document |
| July 19, 2019 Filed Jul 29, 2019 12:35 UTC | Mobiquity Technologies, Inc. MOBQ · Entity 7618 | GrantWarrants · Derivative | 1,562,500 | Not disclosed Strike: $0.12 | Not disclosed |
DisclosureSEC source: 0001683168-19-002366 · ownership.xml · derivative · entry 2 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,812,500 Underlying: Common Stock · 1,562,500 shares Expires 2023-09-30 F2 · price: Not applicable. Read SEC document |
| July 19, 2019 Filed Jul 29, 2019 12:35 UTC | Mobiquity Technologies, Inc. MOBQ · Entity 7618 | GrantCommon Stock | 3,125,000 | $0.08 | $250,000.00 |
DisclosureSEC source: 0001683168-19-002366 · ownership.xml · nonDerivative · entry 1 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,318,355 F1 · balance_after: Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares. Read SEC document |
| July 14, 2019 Filed Jul 29, 2019 12:32 UTC | Mobiquity Technologies, Inc. MOBQ · Entity 7618 | GrantCommon Stock | 12,500,000 | $0.04 | $500,000.00 |
DisclosureSEC source: 0001683168-19-002365 · ownership.xml · nonDerivative · entry 1 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,193,355 F1 · balance_after: Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares. Read SEC document |
| June 18, 2019 Filed Jul 29, 2019 12:30 UTC | Mobiquity Technologies, Inc. MOBQ · Entity 7618 | GrantWarrants · Derivative | 1,562,500 | Not disclosed Strike: $0.12 | Not disclosed |
DisclosureSEC source: 0001683168-19-002364 · ownership.xml · derivative · entry 2 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,250,000 Underlying: Common Stock · 1,562,500 shares Expires 2023-09-30 F2 · price: Not applicable. Read SEC document |
| June 18, 2019 Filed Jul 29, 2019 12:30 UTC | Mobiquity Technologies, Inc. MOBQ · Entity 7618 | GrantCommon Stock | 3,125,000 | $0.08 | $250,000.00 |
DisclosureSEC source: 0001683168-19-002364 · ownership.xml · nonDerivative · entry 1 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,693,355 F1 · balance_after: Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares. Read SEC document |
| May 03, 2019 Filed May 22, 2019 18:52 UTC | Mobiquity Technologies, Inc. MOBQ · Entity 7618 | GrantWarrants · Derivative | 3,437,500 | Not disclosed Strike: $0.12 | Not disclosed |
DisclosureSEC source: 0001683168-19-001688 · ownership.xml · derivative · entry 2 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,687,500 Underlying: Common Stock · 3,437,500 shares Expires 2023-09-30 F2 · price: Not applicable. Read SEC document |
| May 03, 2019 Filed May 22, 2019 18:52 UTC | Mobiquity Technologies, Inc. MOBQ · Entity 7618 | GrantCommon Stock | 6,875,000 | $0.08 | $550,000.00 |
DisclosureSEC source: 0001683168-19-001688 · ownership.xml · nonDerivative · entry 1 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,658,355 F1 · balance_after: Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares. Read SEC document |
| April 03, 2019 Filed Apr 4, 2019 21:20 UTC | Mobiquity Technologies, Inc. MOBQ · Entity 7618 | GrantWarrants · Derivative | 6,250,000 | Not disclosed Strike: $0.12 | Not disclosed |
DisclosureSEC source: 0001683168-19-000951 · ownership.xml · derivative · entry 2 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,250,000 Underlying: Common Stock · 6,250,000 shares Expires 2023-09-30 F2 · price: Not applicable. Read SEC document |
| April 03, 2019 Filed Apr 4, 2019 21:20 UTC | Mobiquity Technologies, Inc. MOBQ · Entity 7618 | GrantCommon Stock | 12,500,000 | $0.08 | $1,000,000.00 |
DisclosureSEC source: 0001683168-19-000951 · ownership.xml · nonDerivative · entry 1 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,783,355 F1 · balance_after: Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares. Read SEC document |
| January 14, 2019 Filed Feb 26, 2019 15:59 UTC | Mobiquity Technologies, Inc. MOBQ · Entity 7618 | OtherConvertible Notes · Derivative | 1,000,000 | Not disclosed Strike: $0.02 | Not disclosed |
DisclosureSEC source: 0001683168-19-000496 · ownership.xml · derivative · entry 2 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000,000 Underlying: Common Stock · 50,000,000 shares Expires not disclosed F2 · price: Not Applicable. F2 · derivative.expiration_date: Not Applicable. Read SEC document |
| January 14, 2019 Filed Feb 26, 2019 15:59 UTC | Mobiquity Technologies, Inc. MOBQ · Entity 7618 | OtherCommon Stock | 50,000,000 | $0.02 | $1,000,000.00 |
DisclosureSEC source: 0001683168-19-000496 · ownership.xml · nonDerivative · entry 1 Salkind Gene · CIK 0001592481 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,283,355 F1 · balance_after: Excludes Preferred StockConvertible into 150 Milion Common Shares and Warrants to purchase an additional 150 million Common Shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.